Charles River Laboratories is approaching its optimal capacity utilisation but says pricing will not improve until the rest of the preclinical CRO industry follows suit.
Harlan Laboratories has followed 2011 cutbacks and consolidation measures with plans to invest and expand its preclinical services site in Itingen, Switzerland.
CRO Toxikon is expanding its efficacy and surgical research services (ESRS) unit in Bedford, Massachusetts to bolster its preclinical services offering for drug and medical device developers.
reMYND NV is to offer the A4 amyloid testing service to support preclinical screening of Alzheimer’s treatments after inking a deal with Amorfix Life Sciences.
In 25 years most biotechs will be virtual, according to a director of preclinical CRO L2D who formed the company with a “completely novel business model” to target this huge growth opportunity.